ZANELLATO, Ilaria
 Distribuzione geografica
Continente #
EU - Europa 1.026
NA - Nord America 992
AS - Asia 273
SA - Sud America 4
Continente sconosciuto - Info sul continente non disponibili 2
AF - Africa 1
Totale 2.298
Nazione #
US - Stati Uniti d'America 970
IE - Irlanda 311
DE - Germania 205
SE - Svezia 173
IT - Italia 136
UA - Ucraina 110
CN - Cina 80
HK - Hong Kong 70
IN - India 58
FI - Finlandia 57
SG - Singapore 36
CA - Canada 22
IR - Iran 15
GB - Regno Unito 10
BE - Belgio 7
VN - Vietnam 6
RO - Romania 5
TR - Turchia 5
BR - Brasile 4
FR - Francia 4
AL - Albania 2
AT - Austria 2
EU - Europa 2
HR - Croazia 2
ID - Indonesia 2
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
JP - Giappone 1
Totale 2.298
Città #
Dublin 311
Jacksonville 211
Dearborn 107
Chandler 93
Hong Kong 70
Piemonte 62
Wilmington 57
Ann Arbor 48
Lawrence 34
Princeton 34
Beijing 32
San Mateo 29
Grafing 26
Bremen 25
Ashburn 18
Toronto 18
Andover 17
Munich 16
Singapore 15
Leawood 13
Zanjan 8
Brussels 7
Hefei 7
Monmouth Junction 7
Woodbridge 7
Dong Ket 6
Helsinki 6
Kunming 6
Nanjing 6
Udine 6
Boardman 5
Kocaeli 5
Los Angeles 5
Ardabil 4
Cave Creek 4
Fairfield 4
Gunzenhausen 4
Hebei 4
Sacramento 4
Wuhan 4
Augusta 3
Berlin 3
Dallas 3
Houston 3
Jinan 3
Milan 3
Norwalk 3
Shenyang 3
Trieste 3
Winnipeg 3
Ahmedabad 2
Cambridge 2
Celle 2
Chengdu 2
Fuzhou 2
Henderson 2
Innsbruck 2
Lerici 2
Monzuno 2
New York 2
Novara 2
Pavia 2
Pelotas 2
Seattle 2
Sumedang 2
Torino 2
Varanasi 2
Zagreb 2
Alba 1
Asti 1
Bellinzago Novarese 1
Brno 1
Busalla 1
Changchun 1
Changsha 1
Chaoyang 1
Chapel Hill 1
Chongqing 1
Genzano Di Roma 1
Grafenhausen 1
Hamilton 1
Harbin 1
La Canada Flintridge 1
Lomazzo 1
Madrid 1
Ningbo 1
Novi Ligure 1
Palo Del Colle 1
Paris 1
Quzhou 1
Redmond 1
Redwood City 1
Rio De Janeiro 1
Rome 1
Savignano Sul Panaro 1
Sotto 1
Taizhou 1
Travaco Siccomario 1
Ueda 1
Valenza 1
Totale 1.443
Nome #
Cisplatin and valproate released from the bifunctional [Pt(IV)Cl2(NH3)2(valproato)2] antitumor prodrug or from liposome formulations: who does what? 90
Different strategies to exploit Pt(IV) complexes as pro-drugs 86
The antiproliferative activity of dicobalt-hexacarbonyl-aspirin complex on different malignant pleural mesotelioma phenotypes 85
Cellular trafficking, accumulation and DNA platination of a series of cisplatin-based dicarboxylato Pt(IV) prodrugs 79
Moving the paradigm in platinum-based chemotherapy from Pt(II) to Pt(IV) complexes? 77
Pt(IV) Bifunctional Prodrug Containing 2-(2-Propynyl)octanoato Axial Ligand: Induction of Immunogenic Cell Death on Colon Cancer 74
Hybrid inorganic (nonporous silica)/organic (alginate) core-shell platform for targeting a cisplatin-based Pt(IV) anticancer prodrug 73
Beyond the Pt(II)-based chemotherapy: Pt(IV) complexes as oral anticancer pro-drugs 71
Antiproliferative activity of Pt(IV)-bis(carboxylato) conjugates on malignant pleural mesothelioma cells 71
Host-guest inclusion systems of Pt(IV)-bis(benzoato) anticancer drug candidates and cyclodextrins 70
Antiproliferative activity of a series of cisplatin-based Pt(IV)-acetylamido/carboxylato prodrugs 69
New Platinum-Based Prodrug Pt(IV)Ac-POA: Antitumour Effects in Rat C6 Glioblastoma Cells 68
Functional fluorescent nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 65
Two are (not always) better than one: the case of bifunctional platinum(IV) drugs 64
Synthesis, characterization and antiproliferative activity on mesothelioma cell lines of bis(carboxylato)platinum(IV) complexes based on picoplatin 62
Biological activity of a series of cisplatin-based aliphatic bis(carboxylato) Pt(IV) prodrugs: How long the organic chain should be? 62
May glutamine addiction drive the delivery of antitumor cisplatin-based Pt(IV) prodrugs? 62
Functionalized nonporous silica nanoparticles as carriers for Pt(IV) anticancer prodrugs 62
The hexacarbonyldicobalt derivative of aspirin acts as a CO-releasing NSAID on malignant mesothelioma cells 61
Synthesis and characterization of cyclohexane-1R,2R-diamine-based Pt(iv) dicarboxylato anticancer prodrugs: their selective activity against human colon cancer cell lines 61
The cisplatin-based Pt(IV)-diclorofibrato multi-action anticancer prodrug exhibits excellent performances also under hypoxic conditions 61
Pt(IV) – histone deacetylase inhibitor conjugates for citotoxicity studies on MPM cells 60
Pt(IV) complexes as anticancer prodrugs 60
An unsymmetric cisplatin-based Pt(IV) derivative containing 2-(2-propynyl)octanoate: A very efficient multi-action antitumor prodrug candidate 60
JQ1, a BET Inhibitor, Synergizes with Cisplatin and Induces Apoptosis in Highly Chemoresistant Malignant Pleural Mesothelioma Cells 60
Evaluation of Platinum–Ethacrynic Acid Conjugates in the Treatment of Mesothelioma 58
Pros and cons of bifunctional platinum drugs: two are (not always) better than one 58
Antiproliferative effect of ferrocifen drug candidates on malignant pleural mesothelioma cell lines 58
Synthesis, characterization and antiproliferative activity of platinum(IV) derivates of picoplatin 57
Polyanionic Biopolymers for the Delivery of Pt(II) Cationic Antiproliferative Complexes 56
Bifunctional Pt-ethacrynic acid conjugates for malignant mesothelioma 55
Metallo-drugs in the Treatment of Malignant Pleural Mesothelioma 54
Platinum-bisphosphonate complexes have proven to be inactive chemotherapeutics targeted for malignant mesothelioma because of inappropriate hydrolysis 54
Cis,cis,trans-[PtIVCl2(NH3)2(perillato)2], a dual-action prodrug with excellent cytotoxic and antimetastatic activity 53
In vitro anti-mesothelioma activity of cisplatin–gemcitabine combinations: evidence for sequence-dependent effects 52
Bifunctional Ethacrynic Acid – Pt Conjugates: In vitro Treatment of Malignant Pleural Mesothelioma 51
Adenomatoid hyperplasia of the upper lip 23
Effects of Ferrocene and Ferrocenium on MCF-7 Breast Cancer Cells and Interconnection with Regulated Cell Death Pathways 2
Totale 2.344
Categoria #
all - tutte 10.617
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.617


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020453 0 1 35 6 58 71 97 23 47 72 39 4
2020/2021310 35 6 38 4 37 14 37 1 52 34 39 13
2021/2022324 35 2 28 29 24 0 43 3 12 5 72 71
2022/2023716 36 29 48 14 58 82 23 31 340 9 37 9
2023/2024238 18 25 25 5 38 2 45 7 3 3 45 22
2024/202522 5 17 0 0 0 0 0 0 0 0 0 0
Totale 2.344